Amgen Sees FY24 EPS $19.20-$20.00 Vs $19.49
Portfolio Pulse from Benzinga Newsdesk
Amgen has released its fiscal year 2024 earnings per share (EPS) guidance, projecting a range of $19.20 to $20.00. This is compared to the previous EPS of $19.49.
October 30, 2024 | 8:22 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Amgen has provided its FY24 EPS guidance, estimating a range of $19.20 to $20.00, compared to the previous EPS of $19.49. This guidance suggests a stable to slightly positive outlook for the company's earnings.
The EPS guidance provided by Amgen is slightly above the previous EPS of $19.49, indicating a stable to slightly positive outlook. This could lead to a positive short-term impact on the stock price as investors may view the guidance as a sign of confidence in the company's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100